Improving Outcomes Through Proactive Monitoring of Transplant Patients– The current goal of transplant medicine and immunology is to develop strategies to extend the life and functionality of every allograft. While outcomes of renal and liver transplantation have improved, allograft loss remains a substantial problem associated with increased morbidity, mortality, and costs.1 Identifying the pathologic pathways responsible for allograft loss and developing targeted therapeutic interventions are currently some of the biggest challenges in transplant medicine. Education to clinicians about the various factors that can result in allograft loss and optimal treatment can improve the quality of life of transplant patients.
Assess for DSA HLA antibodies to prevent antibody-mediated rejection in kidney and liver transplants.
Implement regular monitoring strategies that can optimize appropriate immunosuppressant dosing.
Engage transplant patients to participate in decisions about their treatment to improve outcomes.
1.5 Free CEUs for Social Workers
This course also offers Free CME for Physicians, Nurse Practitioners, and Pharmacists